Globus Medical Return on Investment 2010-2022 | GMED

Current and historical return on investment (ROI) values for Globus Medical (GMED) over the last 10 years.
Globus Medical ROI - Return on Investment Historical Data
Date TTM Net Income LT Investments & Debt Return on Investment
2022-09-30 $0.19B inf%
2022-06-30 $0.19B inf%
2022-03-31 $0.16B inf%
2021-12-31 $0.17B inf%
2021-09-30 $0.21B inf%
2021-06-30 $0.21B inf%
2021-03-31 $0.14B inf%
2020-12-31 $0.11B inf%
2020-09-30 $0.10B inf%
2020-06-30 $0.09B inf%
2020-03-31 $0.16B inf%
2019-12-31 $0.17B inf%
2019-09-30 $0.17B inf%
2019-06-30 $0.16B inf%
2019-03-31 $0.16B inf%
2018-12-31 $0.17B inf%
2018-09-30 $0.17B inf%
2018-06-30 $0.17B inf%
2018-03-31 $0.17B inf%
2017-12-31 $0.16B inf%
2017-09-30 $0.15B inf%
2017-06-30 $0.15B inf%
2017-03-31 $0.15B inf%
2016-12-31 $0.16B inf%
2016-09-30 $0.18B inf%
2016-06-30 $0.18B inf%
2016-03-31 $0.18B inf%
2015-12-31 $0.17B inf%
2015-09-30 $0.16B inf%
2015-06-30 $0.15B inf%
2015-03-31 $0.15B inf%
2014-12-31 $0.14B inf%
2014-09-30 $0.13B inf%
2014-06-30 $0.13B inf%
2014-03-31 $0.11B inf%
2013-12-31 $0.10B inf%
2013-09-30 $0.10B inf%
2013-06-30 $0.10B inf%
2013-03-31 $0.12B inf%
2012-12-31 $0.12B inf%
2012-09-30 $0.11B inf%
2012-06-30 $0.11B inf%
2012-03-31 $0.10B inf%
2011-12-31 $0.10B inf%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $7.483B $0.958B
Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its sales operations distributed across counties world wide. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and unique surgical instruments, used in an expansive range of spinal, orthopedic and neurosurgical procedures. The spine products address the vast majority of conditions affecting the spine including degenerative conditions, deformity, tumors and trauma. Enabling Technologies are designed to enhance a surgeon's capabilities and streamline the complicated surgical procedures to be safer, less invasive, accurate and more reproducible to improve patient care and reduce radiation exposure for both patient and caregiver. The technology contains imaging, navigation and robotic assisted surgery solutions. It acquired all assets of StelKast, Inc. and Finnish engineering company Synoste Oy.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $220.806B 23.09
Edwards Lifesciences (EW) United States $47.328B 32.57
Alcon (ALC) Switzerland $34.365B 29.59
STERIS (STE) Ireland $19.157B 23.84
Teleflex (TFX) United States $11.378B 18.46
Fresenius Medical Care AG KGaA (FMS) Germany $9.600B 9.64
Penumbra (PEN) United States $8.008B 1916.82
Integer Holdings (ITGR) United States $2.426B 19.47
Glaukos (GKOS) United States $2.281B 0.00
Nevro (NVRO) United States $1.601B 0.00
Paragon 28 (FNA) United States $1.511B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.261B 17.96
Artivion (AORT) United States $0.546B 0.00